We describe results of a 3-year study in which 499 paired venous and capillary blood specimens, collected by fingerstick on the same day, were analyzed for lead (BPb) and erythrocyte protoporphyrin (EP). False-positive rates (FPRs) and the proportion of false positives were calculated at four BPb thresholds. At the 100 g/L threshold, the FPR for all data was 13%, but the proportion of false positives was only 5%. The log ratios of capillary-to-venous BPb data indicate that, with the exception of eight outliers, two subpopulations exist that follow a log-normal distribution. These two subpopulations, the "core" (n ‫؍‬ 303) and "shifted" (n ‫؍‬ 188) groups, on average generated a positive bias at 100 g/L BPb of 8.6% and 30.3%, respectively. The log ratios of capillary-to-venous EP data followed a normal distribution, indicating that capillary EP is not statistically different from venous EP.
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INDEXING TERMS: pediatric laboratory medicine • contamination • atomic absorption spectrometry • poisoning • erythrocyte protoporphyrin • false-positive errors Childhood lead poisoning is arguably one of the most preventable environmental diseases. Over the last 25 years, public health agencies have been committed to screening children at high risk for Pb exposure, and to identifying the primary sources. This period has also witnessed perhaps one of the most successful environmental health policies in the US, i.e., the reduction of Pb in the environment, particularly in its removal from gasoline. This has been followed by a substantial decrease in blood lead (BPb) concentrations in the general population. 5 The Third National Health and Nutrition Examination Survey (NHANES III), conducted between 1988 and 1991, estimated the geometric mean BPb concentration in the US as 28 g/L 6 or 0.14 mol/L, a substantial decrease compared with NHANES II (1976 -1980) , where the geometric mean was estimated as 128 g/L or 0.62 mol/L [1, 2] .
In 1991, the CDC revised their recommendations for preventing childhood Pb poisoning [3] . The concentration of Pb in blood deemed "safe" was lowered from 250 g/L (1.2 mol/L) to 100 g/L (0.048 mol/L). In recommending this lower threshold, the CDC rendered the erythrocyte protoporphyrin (EP) test for Pb exposure virtually ineffective.
From the late 1970s to the early 1990s, the EP test was widely used throughout the US to screen children for Pb exposure. In the 1970s, EP screening was deemed reasonably successful for several reasons. The analysis was relatively easy to perform with simple fluorescence methods that required only a small volume of blood (Ͻ100 L) obtained via a fingerstick. Second, the cost of the test was very much less than a blood Pb test. Third, there were no environmental contamination problems associated with the EP test, even when done with small capillary blood specimens. At that time, however, the blood Pb test could be particularly troublesome for clinical laboratories unexperienced in contamination control procedures that are routine in trace element analysis. The use of the EP test became even more widespread with the availability of hematofluorometers, small portable instruments that were designed to measure EP at the point of screening by Drug Monitoring and Toxicology nontechnical personnel. All increased EP concentrations had to be confirmed with a blood Pb test, however, before a diagnosis of Pb poisoning could be made.
At the lower BPb threshold of 100 g/L, the diagnostic sensitivity of EP as a predictor of an increased blood Pb concentration falls to Ͻ50%, i.e., more than half of the children screened by EP are considered false negative for predicting a BPb concentration Ͼ150 g/L [4] . In light of research that characterized the poor performance of EP, even at the previous blood Pb threshold of 250 g/L, the CDC recommended the use of a direct BPb measurement for both screening and diagnostic purposes. In the wake of these major changes in public health policy recommendations, many felt that the transition to use of a direct BPb measurement could not be accomplished easily [5] . One major concern was the likelihood of severe contamination errors from Pb in the environment that could make BPb screening unworkable, especially at the lower concentration threshold of 100 g/L. Before 1991, there were few studies of the extent of the contamination problem. Although several public health programs across the US were successfully using "micro" BPb tests for screening purposes, many others had little experience in analysis for blood Pb.
One of the earliest studies of Pb contamination was published in 1974 by this laboratory [6] . At the time, the concentration of Pb deemed safe was 400 g/L [7] , and the mean BPb concentration recorded in the laboratory was 250 g/L, i.e., almost 10 times higher than the current US population mean. In 1974, the laboratory's collection protocol recommended the use of a collodion barrier spray product to reduce Pb contamination. By 1991, collodion spray had given way to a silicone barrier spray product, which further enhanced the "beading" of the capillary blood drop, thus facilitating its transfer into a glass microhematocrit tube.
In 1992, this laboratory embarked on a project to reexamine the scientific rationale for using a silicone barrier spray to reduce Pb contamination errors. The laboratory was one of three selected by the CDC to examine the issue of capillary blood collection techniques, and to assess the extent of contamination from Pb that occurred during the blood collection process. The two other centers were the Yale University School of Medicine and the City of Milwaukee Health Department. Both of those groups have reported their results elsewhere [8, 9] .
Here we describe the results of a 3-year study that includes Ͼ500 matched pairs of venous and capillary blood specimens collected on the same day during routine visits to a private pediatric healthcare provider or a public health Pb screening program. The study also includes an evaluation of the silicone barrier spray as a means of reducing contamination errors from exogenous Pb on the skin surface, and explores the factors that contribute to contamination errors. Before the study, extensive laboratory analyses were conducted on several commercial microcollection devices to evaluate the amount of Pb contamination arising from the collection device and (or) its additives. Additionally, we also examined the validity of using capillary blood obtained by fingerstick as a surrogate for venous blood by comparing analytical results obtained for EP, which is not subject to environmental contamination errors but which, like Pb, is concentrated in erythrocytes.
Materials and Methods study design
Initially, human subjects were recruited into the study through several Pb screening clinics operated in New York State by the Westchester County Department of Health, White Plains, NY. These Pb screening clinics were conducted at the county's district offices located in New Rochelle, NY and Rye Brook, NY. These district offices serve an urban population of children without private health insurance, many of whom are eligible for Medicaid. A total of 74 matched blood samples were obtained before staff changes within the county health department led to a cessation in participation. An attempt was made to enlist the participation of the Suffolk County Department of Health's Pb screening program, located on Long Island in Hauppauge, NY but, after initially providing only 13 matched blood samples, the program declined to participate further owing to a reduction of personnel resources allocated to conduct Pb screening.
The majority of study subjects were finally recruited through a collaborative arrangement with the Division of General Pediatrics, North Shore University Hospital, Manhasset, NY. This is a suburban pediatric healthcare practice located on Long Island, NY and affiliated with the Department of Pediatrics of North Shore University Hospital. The Division of General Pediatrics operates an office-based pediatric practice. The Division offers both primary care and pediatric consultation in an academic environment, which serves and provides an educational forum for training medical students and postgraduate residents. The Division provides primary care for children living in the vicinity of North Shore University Hospital as well as communities in the New York metropolitan areas of Queens and Brooklyn. The Division currently provides care for ϳ10 000 families. A total of 446 matched venous-capillary blood specimens were received from the Division of General Pediatrics over a 3-year period; this represents 84% of the specimens collected in this study. Capillary and venous blood samples were collected by a 14-member pediatric healthcare staff.
Subjects were enrolled into the study during scheduled follow-up visits to the Westchester/Suffolk County Health Department Pb clinics, or during scheduled pediatric visits to the North Shore office, where routine venipuncture was being performed, either for a confirmatory BPb or for other test purposes. The motivation and goals for this study were carefully explained and, after the informed consent of the parent/guardian, the subject received a fingerstick in addition to venipuncture. The Venous and capillary blood specimens drawn during the same office visits were mailed to the laboratory for analysis in the same package within 5 business days. Capillary blood was analyzed and the results were used for research purposes only; however, results of venous specimens were reported directly to the physician or authorized person ordering the test.
Matched venous and capillary blood specimens were collected from 533 children residing in New York State at ages 0 -12 years (68%, 1-4 years) during the 3-year study period. Males constituted 57% of the sample. Racial/ ethnic designations in the sample population were 38% Caucasian, 28% African American, 21% Hispanic, and 6% Asian. Each institution employed several staff members who were involved in collecting blood, and a total of 28 participated in the study, of whom 9 accounted for 95% of the samples collected. Time between collection and analysis in the laboratory varied from 1 to 14 days (85%, 3-6 days); stored specimens were refrigerated before analysis. Blood specimens for Pb and (or) EP determinations may be stored for up to 8 weeks refrigerated without degradation [10] . For EP measurements, specimens must be protected from prolonged exposure to light.
Analyses for both BPb and EP were carried out on venous and capillary blood specimens whenever specimen volume permitted. As a matter of priority, capillary blood Pb measurements were performed before those for EP, since capillary blood volume was limited.
protocols
Specimen collection. Although county health personnel were already familiar with fingerstick Pb screening protocols, all healthcare personnel involved in this study were given a single "hands-on" training workshop on collecting "clean" capillary blood specimens by using one of two collection protocols. Thereafter, periodic in-service training was provided by senior pediatric healthcare staff at the screening institution. Both collection protocols are consistent with the recommendations of the NCCLS' subcommittee on collection of blood specimens by skin puncture [11] , but are modified to minimize Pb contamination errors and expedite specimen transfer into plastic Pb-free microcollection tubes, rather than a glass microhematocrit tube. 7 It is recommended that all staff follow the CDC universal precautions when collecting and analyzing blood specimens. In particular, only powder-free latex gloves should be used to avoid potential contamination. Both protocols call for vigorous washing of the child's hands with soap and water, and covering the hand with a paper towel to prevent contamination before puncturing the finger. The middle or "ring" finger is selected, wiped with an alcohol swab, and dried with a gauze pad. Under protocol B, an additional step is required to apply a thin film of silicone to the finger. After puncturing the finger, the patient's hand is turned over so that blood drops form toward the floor. The first blood drop is removed with the gauze pad and further blood drops allowed to fall into the collection device. It is important to avoid scooping blood directly from the skin surface. Gently massaging the finger to promote good blood flow is acceptable. Aggressively "milking" the finger is not acceptable. Good blood flow should produce 200 -500 L, although it is still possible to analyze volumes of blood Ͻ200 L. After collecting sufficient blood, the collection device is securely capped and vigorously shaken. This latter step is critical to ensure complete and thorough mixing with the anticoagulant to avoid fibrin clot formation.
Each collecting site performed one of the two protocols over a fixed period of 6 months to a year, after which the alternate protocol was used. Collectors were asked to record on the BPb test requisition slip whether silicone spray was used, to prevent errors in assigning the analytical data to one or the other protocol. A total of 257 pairs (51.5%) were collected with the silicone barrier spray.
All collection materials for this study were provided by the Wadsworth Center's Lead Poisoning/Trace Elements Laboratory. Before being placed into use, samples of blood collection tubes, lancets, and needles were checked for gross Pb contamination. Several plastic microcollection devices were evaluated for Pb screening purposes. The outcome of this evaluation led to selection of plastic lavender-capped Microtainer tubes 8 (Becton Dickinson, Franklin Lakes, NJ) containing K 2 EDTA for collecting capillary blood for both Pb and EP determinations. The minimum fill volume for Microtainer tubes is 200 -250 L, depending on the product model, although only 50 L of whole blood is actually required for a single BPb determination. Microtainer tubes were checked on a lot-by-lot basis for Pb contamination by using a simple blood leaching procedure and certified by the laboratory for Pb screening purposes.
Laboratory studies indicate that some residual Pb in plastic microcollection devices may contribute a small "background" Pb value of 2-3 g/L. Over a 4-year period, 24 different batches of B-D Microtainer tubes were screened for gross systematic Pb contamination. The criterion for rejecting a batch for routine Pb screening purposes is if the Pb content raises the endogenous BPb concentration by Ͼ5 g/L, i.e., by Ͼ5% at 100 g/L, assuming a minimum fill volume of 250 L. In 4 years, 7 Detailed instructions for collecting capillary whole-blood specimens for Pb testing are available from the corresponding author upon request.
two of 10 batches have failed to meet this criterion. Most recently, a batch was detected that would have increased BPb concentrations by 110 g/L. No significant Pb contamination has yet been found in other supplies used to collect blood specimens for Pb testing, i.e., lancets and needles, although some batches of evacuated blood collection tubes have proven unsuitable. This situation only underscores the necessity for using supplies that have been prescreened for Pb contamination.
Micro lancets were also checked on a lot-by-lot basis for Pb contamination by using a simple acetic acid leach test and were also provided by the laboratory as part of the Pb screening kit. We used yellow Microtainer Safety Microlancets (Becton Dickinson) with a puncture depth of 2.2 mm, which is consistent with the NCCLS recommendations for skin puncture [11] . The manufacturer suggests use of a smaller puncture depth for infants, but our experience has been that, for pediatric populations ages 12-18 months, it is preferable to achieve a good puncture, and thus good blood flow, at the first attempt and avoid the potential for insufficient blood quantity, clotting, and other problems as well as the additional trauma of repeating the procedure. Venous blood collection materials, prescreened for Pb contamination, were provided. We used either Monoject (Sherwood Medical, St. Louis, MO) or Vacutainer Tube (Becton Dickinson) brand evacuated tubes with lavender caps, i.e., K 2 EDTA preservative.
The silicone barrier spray consisted of medical-grade silicone in ethanol (Trace Metal Instruments, West Palm Beach, FL). The direct determination of Pb proved difficult because of matrix effects from silicone oil and (or) ethanol. Therefore, 100-L aliquots of reference low-Pb animal blood were placed on 20 microscope glass cover slides that had been sprayed with the product. After 5 min, 50-L samples were analyzed for Pb. No significant contamination was found. We concluded that any residual Pb in this product was not available to contaminate the blood specimen.
analytical methods

Determination of Pb in blood.
The determination of Pb in blood was carried out with a well-established method based on graphite furnace atomic absorption spectrometry (GFAAS) [12] . This method has been thoroughly validated against national and international blood Pb reference materials from the NIST (Gaithersburg, MD), the Commission of the European Communities, Community Bureau of Reference, Belgium, and the CDC Blood Lead Laboratory Reference System. The Wadsworth Center's Lead Poisoning/Trace Elements Laboratory serves as a referee laboratory in several national proficiency testing programs for BPb and EP (New York, Wisconsin, and Pennsylvania). The laboratory also participates successfully in several international interlaboratory programs for BPb. For the purposes of this study, all blood specimens were analyzed for Pb in triplicate wherever possible. The routine precision of the laboratory's BPb method, expressed as SD, is Ϯ 2.5 g/L in the range 100 -200 g/L. The routine accuracy of the method is almost always better than 15 g/L below 400 g/L, and rarely worse than 5% above that.
Determination of EP.
The primary focus of this study was the determination of BPb, and this was certainly the priority for the capillary blood specimens. The analysis for EP was secondary, and was conducted only if the analysis for BPb had been successfully completed and blood quantity permitted. Since capillary blood volume is small, there were some instances in which insufficient blood volume remained to complete the test for EP. Where paired analyses for EP were possible, the results served to test whether there was a significant difference in EP values obtained for the two kinds of blood specimen. Analyses for EP were carried out with a consensus reference method that is similar to the proposed NCCLS standard method [13] . The analytical results for EP were calculated on the basis of a millimolar absorptivity for protoporphyrin IX (PPIX) of 241. 9 The laboratory participates as a referee lab in several proficiency testing programs for EP.
Statistical methods.
A false-positive result is defined as an increased capillary BPb of Ͼ10 g/L above the paired venous BPb result at a defined threshold. This rather stringent definition is based on the statistical uncertainty of BPb results analyzed in the same laboratory on the same day. Since the precision (SD) of the laboratory's BPb method permits reporting results to better than Ϯ 10 g/L, this condition is required to avoid misclassifications that would result from differences Ͻ10 g/L. Similarly, a false-negative result is defined as a capillary BPb result that is at least 10 g/L less than the paired venous BPb result at a defined threshold. Thus, values were considered identical for clinical test performance purposes if the difference between the two was Ͻ10 g/L, i.e., Ͻ1.0 g/dL.
There has been some confusion in the literature over the nomenclature used to describe false-positive errors in BPb screening with respect to the use of the term "falsepositive rate" (FPR). Schlenker et al. [9] defined the FPR as the fraction of false positives found in the total population screened for Pb. Schonfeld et al. [8] defined the FPR as 1 Ϫ the positive predictive value, i.e., the negative predictive value (NPV), which is the probability that venous BPb is not increased given that capillary BPb is increased. Thus, FPR is calculated as: FPR ϭ total number of false positives total number of positives ϫ 100.
Although interpretation of the FPR in terms of the NPV is only valid when the sampling is proportional to the prevalence, FPR is, nonetheless, dependent on the underlying prevalence of the condition such that in areas of low prevalence it will be increased. We agree with Schlenker in his response to Rainey and Schonfeld [14] that, in low-prevalence populations, positive results, true and false alike, will be few and, therefore, in a practical public health context, where the concern is to minimize contamination errors, it is more meaningful to report false positives as a fraction of the total number of children screened. We call this parameter the false-positive proportion (FPP) to avoid confusion with the FPR. It is calculated as:
FPP ϭ total number of false positives total number screened ϫ 100.
The significance of using silicone spray, the specific collection site, the collector, sex, race, and seasonal variation was assessed by stepwise weighted least-squares regression, and associated Student's t-tests. Weights were determined via maximum likelihood estimation of mixtures of normal distributions by using the expectation maximization algorithm after likelihood ratio testing for the number of required components [15] . All statistical calculations were carried out with APL*PLUS II/UNIX version 5, 1993 (Manugistics, Rockville, MD).
Results
A total of 533 venous and capillary blood pairs drawn on the same day were collected over a 3-year period, April 1992 to August 1995. Two standardized collection protocols, A and B, were used in the study as described in Materials and Methods. Protocol A called for the child's hand to be scrubbed vigorously with soap and water (n ϭ 278). Protocol B also called for the child's hand to be scrubbed vigorously with soap and water, but included an additional step in which a silicone barrier spray was applied to the child's finger after washing but before the puncture (n ϭ 255). Of the 533 capillary blood specimens submitted for analysis, 29 (5%) were rejected because of clotting, insufficient sample volume for analysis, use of a non-lead-free tube, or a laboratory accident. The 5% excess rejections among the capillary specimens is statistically significant (P Ͻ0.0001). Only five venous blood specimens (1%) were rejected as unsatisfactory. Therefore, the data were reduced to 499 matched pairs of capillary BPb and venous BPb test results. The proportion (in %) of increased BPb values in the sample for various thresholds are given in Table 1 .
Dichotomizing both venous and capillary BPb results in a two-by-two table based on a specific threshold permits test performance assessment in terms of the FPR and the FPP, with the definitions of the different classes given in Materials and Methods. For the purposes of comparing our data with those from other groups, we report both FPR and FPP parameters, along with specificity and total accuracy, for BPb thresholds at 100, 150, 200, and 250 g/L ( Table 2 ). Confidence intervals (95%) for the FPR and FPP were obtained from the binomial distribution [16] . Figure 1A and B shows two scatterplots of the capillary vs venous BPb data on linear and logarithmic axes respectively, with the dashed line representing the relation y ϭ x. To illustrate test performance in Fig. 1 , two grid lines are identified on the scatterplots at the critical BPb threshold of 150 g/L. The four quadrants in each Fig. repre sent, clockwise from upper left, false positives, true positives, false negatives, and true negatives. Although it is preferable to view the scatterplot on logarithmic scales, since the majority of the data points are clustered below 150 g/L, the corresponding data on linear scales are provided for direct comparison with other published data. The capillary BPb data (median ϭ 78 g/L, SD ϭ 111.1) and venous BPb data (median ϭ 63 g/L, SD ϭ 97.2) both follow log-normal distributions except for slight deficiencies in observations Ͻ20 g/L, which is close to the GFAAS detection limit for Pb. Therefore, differences between the matched results were assessed by using the log ratio of capillary BPb/venous BPb, here called the discrepancy. If no bias were present in the capillary values, the mean discrepancy would be 0, which would correspond to an average capillary/venous ratio of 1 for 0% bias. Statistical analyses were conducted on the log scale to avoid the underweighting of low BPb values (and the overweighting of high values) that occurs if the original skewness is ignored.
However, rather than following a single gaussian form, the distribution of capillary-venous discrepancies was unexpectedly a mixture of three normal populations. Maximum likelihood estimates of the parameters of each normal population and its percent contribution to the overall distribution are displayed in Table 3 . The three normal populations are identified as (see Fig. 2 ): (a) the "core" population, representing 61% of the data, with 9% bias; (b) the "shifted" population, accounting for 38% of the data, with 32% bias; and (c) the "outlier" population consisting of eight observations. Quantile-quantile plots and associated tests confirm, despite the peak of excess observations at 0 discrepancy and various departures in the shifted regions, that the trivariate mixture provides an excellent fit.
In our data analysis we made numerous attempts to model the data with several skewed distributions, including the logarithmic, with various transformations. None provided as clearly a fine fit as the mixture of normals. We considered mixtures of four normal distributions in an attempt to obtain a clean separation of "up"-and "down"-shifted values. The likelihood ratio for including the extra down-shifted distribution was not significant. Conversely, the likelihood ratio test was highly significant when used to test for the inclusion of the up-shifted distribution against an alternative consisting of just the core and outlier distributions. The distribution of individual discrepancies expressed as the natural logarithm of the capillary BPb-venous BPb ratio is also shown in Fig. 2 . Neg  445  437  400  302  135  465  457  415  320  137  TN  433  428  396  300  128  458  452  414  320 Size  499  491  444  349  142  499  491  444  349  142  True  487  482  440  347  135  491  485  442  349 Clinical Chemistry 43, No. 2, 1997 In contrast, the capillary and venous EP discrepancies followed a single gaussian distribution (Fig. 3) .
Multiple weighted linear stepwise regressions for the core and shifted populations were conducted to assess the significance of the various covariables. The predicted relation between capillary and venous BPb measurements for the core (n ϭ 303) and shifted (n ϭ 188) populations is shown in Fig. 4 . The weights in each regression were taken as proportional to the probability that an observation belonged to the population being studied. Weights totaling 303 and 188 were respectively utilized in the core and shifted regressions. Estimates from the combined data are omitted but were a weighted average of the estimates from the separate analyses. The statistical significance of the combined estimates could not be assessed as is the standard technique, relative to a normal distribution, owing to the presence of the mixture.
The regressions tested the effect on capillary BPb of: venous BPb; collection at North Shore University Hospital, the most predominant site (84% of samples); race being white or nonwhite; collection by one of the nine most frequently used individual collectors (95% of the collections); use of the silicone barrier spray as part of the presampling finger preparation (257 pairs); the effect of seasonal variation; and the interaction between venous BPb values and silicone preparation. The latter item was included to assess whether using a silicone barrier spray was more effective at reducing contamination errors among children with increased BPb concentrations. Neither silicone nor its interaction with BPb had a significant effect (P Ͼ0.05). Race and collection site were also not significant. We found a small but marginally significant seasonal change in blood Pb discrepancies in the core population, where a cosine function was found to be the most significant fit (P ϭ 0.048). This small seasonal effect, which could be an artifact of nonrandom sampling, did not significantly alter the parameter estimates reported in Table 4 , when we added it to our regression models. Accounting for seasonality did change the significance of silicone barrier effect in the shifted population from P ϭ 0.84 to P ϭ 0.12, which is still not a statistically significant effect. The largest effect, as expected, was attributed to venous BPb, which reflects its high correlation with capillary values. However, capillary BPb concentrations demonstrated a statistically significant (P Ͻ0.0001) venous BPb-dependent positive bias in both subpopulations (Fig. 4) . The size of this bias, expressed as a percentage, decreased at higher venous BPb concentrations owing to estimated slopes being Ͻ1 (Table 4 , top), and was exaggerated in the shifted population. Note the absolute bias, expressed as g/L BPb, increases at higher BPb. At 100 g/L BPb, the absolute bias is Ͻ10 g/L in the core population, and 30 g/L in the shifted population. Additionally, the core population contained significant (P Ͻ0.05) effects for four of the 28 collectors. A similar effect in the shifted population was detectable for only one collector (Table 4 , bottom).
Discussion
The FPR for the entire population was 17% at 150 g/L and 18% at 250 g/L. The FPRs and FPPs estimated here Fig. 3 . b Probability of belonging to the subpopulation.
are indistinguishable from those reported by Schonfeld et al. [8, 14] (FPR ϭ 7-20%, FPP ϭ 4 -11%, at 150 g/L) and Schlenker et al. [9] (FPR ϭ 8 -25%, FPP ϭ 1-5% at 200 g/L). Indeed, the FPP for our data at 150 g/L was 4%, which is close to the estimate of Schonfeld et al. [14] of 7.6% for their population. At 250 g/L, our FPP dropped to 1%. Although capillary BPb exhibits a positive bias, it is small and is, of course, because of environmental Pb contamination, which leads to false-positive results. A distinct advantage of this investigation is that many children who initially tested negative on the screening test were immediately confirmed to be free of Pb poisoning and, therefore, true negatives. False-positive errors are of concern, but they will be detected and eliminated by the confirmatory venous BPb test. However, since negative results are not subjected to a confirmatory venous BPb test, there is a risk of misdiagnosing as negative a child who would otherwise test positive for Pb poisoning. Thus it is reassuring to know that only one false-negative result was found at 150 g/L and one at 250 g/L, and the differences were Ͻ20 g/L.
The regression analysis demonstrates that few variables affect capillary BPb determinations aside from venous BPb. In particular, in agreement with Schlenker et al. [9] and Schonfeld et al. [8] , pretreatment with silicone did not significantly decrease capillary BPb contamination bias. In another study of capillary blood sampling for BPb measurements in Danish schoolchildren, the use of a plastic film (Nobecutan ® ) sprayed onto the finger was compared with washing the finger with dilute (0.1 mol/L) nitric acid [17] . Those authors found the Nobecutan approach averaged 8% higher than simultaneously drawn venous blood. However, Sargent et al. [18] , using a different barrier (Tegaderm ; 3M Medical-Surgical Division, St. Paul, MN), reported that Pb contamination errors for capillary BPb measurements were reduced compared with capillary blood collected on the same day but without a barrier. They reported a mean difference between venous and capillary-barrier BPb results of 8 g/L vs 29 g/L for capillary BPb measurements drawn without a barrier. However, their study population consisted of only 29 adult volunteers and, as the authors concede, their study does not demonstrate whether such a barrier technique would be effective in the field when screening young children. For the purposes of a public health screening program, eliminating the silicone application Table 3 .
Fitted lines represent population-specific regressions obtained by weighted least squares.
from the finger preparation protocol is an added convenience due to reduced cost, faster collection times, and increased safety for collection site personnel. This latter point is not insignificant, since several of the collectors reported that, when using the pump-spray bottle, some of the silicone spray inevitably ended up on the floor, making it dangerously slippery.
Collector effects were found and two types were identified. In the core population two of the 18 collectors were associated with decreased bias and two with increased bias. In the shifted population, one of the 18 collectors (D) was associated with positive biases of 5-27%. On-site inspection during the study revealed that this collector (D) was not following the recommended protocol for finger preparation, neglecting to wash the child's hand before puncture because a sink was not available in the examination room. Collector D had erroneously assumed that simply using an alcohol wipe before puncture would provide sufficient cleaning of the finger. It was for this reason that we elected to examine in more detail the effect collector D had on the data. Removing collector D's contribution from the data of Table 2 Table 2 . We believe this is evidence of variability among collectors in the thoroughness of finger preparation.
The possible existence of a second shifted population (38%) of mildly contaminated capillary BPb results is surprising and to our knowledge has never been previously reported. In contrast, the existence of the outlier population is consistently reported by others [8, 9] . Utilizing a mixture of normals is convenient, since it permits detailed separate analyses. This has provided some assurance that there are no significant effects of, for example, use of the silicone barrier among observations in either the core or shifted populations. Another possible approach would be to have used a single skewed distribution. However, in addition to losing the ability for detailed analyses, this approach would invalidate t-tests, thus rendering inferences on the significance of effects, such as silicone barrier treatment, difficult or impossible. Outliers are far enough from other data to delineate them clearly. The overlap between core and shifted populations, despite excellent agreement with a normal mixture, does not definitively eliminate the possibility that the discrepancies are simply skewed. This issue must be left for further confirmatory investigations.
Although the existence of significant collector effects points to variability among collectors, neither outliers nor shifted population results could be assigned to a single collector. Three of the 28 collectors were identified as major contributors to the shifted population. As shown at the bottom of Table 4 , collector D was the only one to exhibit a significant bias in both the shifted (15.27%) and core populations (4.07%). A plausible explanation is that collector D was the only one observed not following the established protocol, i.e., neglecting to wash the child's hands because a sink was not available in the patient examination room. In the core population, one other collector exhibited a significant positive bias (3.12%). We cannot explain the basis for the small negative biases (Ϫ3.06%, Ϫ2.72%) observed for two collectors in the core population.
It seems natural to suppose, therefore, that there is also within-collector variability. The shifted and outlier populations would then be plausibly attributable to lapses in proper capillary sampling technique, i.e., insufficient cleaning. The absences of effects of race and collection site are reassuring since they indicate that the data hold no The table gives parameter estimates from the final linear models fit by the weighted stepwise regression of log capillary results on log venous results, and 18 independent variables separately in core and shifted populations. The slopes are coefficients of log venous BPb. A consequence of having slopes Ͻ1 is that the capillary BPb bias decreases as venous BPb increases. This is demonstrated by calculating the % bias at three different venous BPb values to express the regression results on the linear scale. Of the other 18 variables, only 5 were significant (P Ͻ 0.05) and 4 of these were collector effects. Hence evidence suggesting that results must be interpreted within human or clinic subpopulations.
The EP data support the concept that capillary blood is a good reflector of erythrocyte-bound analytes, e.g., protoporphyrin and Pb, found in venous blood. One study compared 12 analyte concentrations in capillary or skinpuncture serum and plasma with concentrations in venous serum [19] . Those authors reported important differences for concentrations of glucose, potassium, total protein, and calcium, with higher values found for all but glucose in venous serum. The probable explanation for the lower concentrations in skin-puncture plasma/serum is that this blood specimen mixes with interstitial fluid. In our study, we analyzed capillary whole-blood specimens drawn in the field for EP as well as for Pb, analytes that were not included in the 1977 study. The results show that capillary blood yields results for EP that are not statistically different from EP results measured in venous blood.
In conclusion, the fact that capillary BPb is highly correlated with but positively biased relative to venous BPb means that its utilization will induce a 5-10% (7.5-15 g/L) bias in BPb determinations at 150 g/L, resulting in a FPR of 1-9% and a FPP of 0 -2% provided that the patient's hands have been thoroughly washed beforehand. Lapses in cleaning technique may lead to an 11-42% bias and concomitant increases in FPR and FPP to 27-58% and 8 -12%, respectively. Vigilant oversight in training, educating, and monitoring collectors is indicated.
